CONTACT
DIAGNOSTICS
ABOUT ABBOTT
i-STAT Registration
i-STAT Login
CUSTOMER HOME
PARTNERS HOME
DISTRIBUTION HOME
EMPLOYEES HOME
REPAIR MANUAL
COMPLETE PROFILE
DASHBOARD
My Account
United States

Global Point of Care

i-STAT cTnI Cartridge

Providing lab-quality results fast when every minute counts.

With i-STAT cardiac troponin I (cTnI), healthcare professionals can obtain quantitative measurement of cardiac troponin I (cTnI) in ten minutes without leaving the patient's side. 

ORDER VIA E-ABBOTT
cTnI_white cTnI_white cTnI_white
Chapter Navigation
Benefits

By incorporating i-STAT cTnI early in the patient experience, measurements of cardiac troponin I can improve diagnosis and treatment of myocardial infarction (MI) and aid in the risk stratification of patients with acute coronary syndromes (ACS) with respect to their relative risk of mortality.

  • The i-STAT cTnI cartridge meets the ACC/AHA guideline of 60-minute turnaround time 98% of the time, compared with 53% for the central lab.6
  • Provides lab-quality results,2 which can improve which can improve risk stratification of ACS (acute coronary syndrome).
  • The 2018 Third Universal Definition of Myocardial Infarction recognizes troponin as the biomarker of choice.3
  • Use of bedside testing in the ED has been shown to reduce:
    • Time to anti-ischemic therapy by approximately 45 minutes5
    • Time to discharge by 24 minutes1
    • ED length of stay by 1.9 hours5

Cartridge Details

 Cardiac Markers

Cardiac Troponin I (cTnI)
Helpful Documents

PRODUCT DOCUMENTS

SPECIFICATIONS

cTnI - INTENDED USE

The i-STAT cardiac troponin I (cTnI) test is an in vitro diagnostic test for the quantitative measurement of cardiac troponin I (cTnI) in whole blood or plasma. Measurements of cardiac troponin I are used in the diagnosis and treatment of myocardial infarction and as an aid in the risk stratification of patients with acute coronary syndromes with respect to their relative risk of mortality.

  • DESCRIPTION: Rapid triage of chest pain patients, including those with ACS
  • SAMPLE SIZE: 17μL
  • SAMPLE TYPE: 
    • Heparinized whole blood or plasma samples collected in syringes or evacuated tubes containing lithium heparin, or
    • Non-heparinized whole blood samples tested within one minute of drawing from a patient into a plastic syringe or plastic evacuated tube containing no additives
Expected Values
 Cardiac Markers
 Reportable Range
Cardiac Troponin I (cTnI)0.00-50.00 ng/mL (µg/L)

Reference ranges (sometimes referred to as normal ranges) in the default Customization profile can be found behind login on the i-STAT Cartridge and Test Information (CTI) Sheets/Instructions for Use (IFU) page.  This page is only accessible to registered i-STAT customers.

1. ACEP Task Force Report on Boarding. Emergency Department Crowding: High-Impact Solutions. Irving, Tex: American College of Emergency Physicians; April 2008.
2. Ryan R, Lindsell C, Hollander J, et al. A multicenter randomized controlled trial comparing central laboratory and point-of-care marker testing strategies: The disposition impacted by serial point of care markers in acute coronary syndromes (DISPO-ACS) trial. Ann Emerg Med. 2009;53:321- 328.
3. Third Universal Definition of Myocardial Infarction (MI), Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe, Maarten L.Simmons, Bernard R. Chaitman and Harvey D. White, Circulation 2012;126:2020-2035 http:www.scpc.org/resources/PDFs/ThirdUniversalDefinitionofMyocardiallnfarction_CIRC2012.pdf
4. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction). Circulation. 2007;116:e148-304.
5. Renaud B, Maison P, Ngako A, et al. Impact of point-of-care testing in the emergency department evaluation and treatment of patients with suspected acute coronary syndromes. Acad Emerg Med. 2008;15:216-224.
6. Apple FS, Murakami MM, Christenson RH, et al. Analytical performance of the i-STAT cardiac troponin I assay. Clin Chim Acta. 2004;345:123-127.

 

PRODUCT CODES

i-STAT SystemCode

i-STAT cardiac troponin I (cTnI)

03P90-25
Related Products

©2023 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement | Declaration for California Compliance Law.

Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.

Abbott - A Leader in Rapid Point-of-Care Diagnostics.